Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
Authors:
- Michalis LiontosMLMichalis Liontos
- Konstantinos VougasKVKonstantinos Vougas
- Theodoros RoumeliotisTRTheodoros Roumeliotis
- Jirina BartkovaJBJirina Bartkova
- Maria SideridouMSMaria Sideridou
- Ayguel Dereli-OzADAyguel Dereli-Oz
- Maciej KocylowskiMKMaciej Kocylowski
- Ioannis S. PaterasIPIoannis S. Pateras
- Kostas EvangelouKEKostas Evangelou
- Athanassios KotsinasAKAthanassios Kotsinas
- Ines OrsolicIOInes Orsolic
- 14 July 2013
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 15 (8) , 967-977
Abstract
The DNA damage response (DDR) pathway and ARF function as barriers to cancer development. Although commonly regarded as operating independently of each other, some studies proposed that ARF is positively regulated by the DDR. Contrary to either scenario, we found that in human oncogene-transformed and cancer cells, ATM suppressed ARF protein levels and activity in a transcription-independent manner. Mechanistically, ATM activated protein phosphatase 1, which antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM), thereby liberating ARF from NPM and rendering it susceptible to degradation by the ULF E3-ubiquitin ligase. In human clinical samples, loss of ATM expression correlated with increased ARF levels and in xenograft and tissue culture models, inhibition of ATM stimulated the tumour-suppressive effects of ARF. These results provide insights into the functional interplay between the DDR and ARF anti-cancer barriers, with implications for tumorigenesis and treatment of advanced tumours.Keywords
This publication has 75 references indexed in Scilit:
- Cdc6 expression represses E-cadherin transcription and activates adjacent replication originsJournal of Cell Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Nucleophosmin and its complex network: a possible therapeutic target in hematological diseasesOncogene, 2011
- TopBP1 functions with 53BP1 in the G1 DNA damage checkpointThe EMBO Journal, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- DNA damage signalling guards against activated oncogenes and tumour progressionOncogene, 2007
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003